CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities
Net income	$ 4,954	$ 6,304	$ 4,776
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense	1,760	1,792	1,647
Amortization of intangibles	5,323	5,581	5,827
Gain on extinguishment of debt			(79)
Bargain purchase gain		(146)
Tax benefit from stock issuances	(310)	(346)	(851)
Amortization of deferred financing costs	141	153	214
Stock-based compensation	5,049	3,107	3,385
Change in fair value of contingent consideration	468	658	1,299
Changes in accounts receivable allowance	174	(100)	49
Deferred tax benefit	(1,958)	(1,789)	(1,814)
Loss on disposal of fixed assets	3	19	66
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(7,506)	(2,321)	897
Prepaid expense and other current assets	(1,820)	(456)	(495)
Accounts payable	(612)	1,121	(48)
Deferred revenue	(372)	953	292
Accrued expenses	1,519	(7,523)	7,890
Net cash provided by operating activities	6,813	7,007	23,055
Cash flows from investing activities
Acquisitions net of cash acquired	(537)	(890)
Restricted cash	(30)	(310)	(2)
Purchase of furniture, fixtures and equipment	(1,378)	(2,170)	(1,901)
Net cash used in investing activities	(1,945)	(3,370)	(1,903)
Cash flows from financing activities
Proceeds from debt			55,000
Principal payments on borrowings	(2,591)	(3,375)	(60,822)
Proceeds from issuance of ESPP shares	581	576	382
Payment of contingent consideration	(2,322)	(1,633)
Installment payment for acquisition of CCI	(661)
Dividend paid	(5,189)
Debt issuance costs			(754)
Tax benefit from stock issuances	310	346	851
Equity securities repurchased	(3,381)	(5,320)	(4,055)
Net cash used in financing activities	(13,253)	(9,406)	(9,398)
Effect of exchange rate changes on cash	(1,442)	(1,654)	(168)
Net (decrease) increase in cash and cash equivalents	(9,827)	(7,423)	11,586
Cash and cash equivalents, beginning of period	27,662	35,085	23,499
Cash and cash equivalents, end of period	17,835	27,662	35,085
Cash paid for:
Interest	1,464	1,785	2,406
Taxes	4,526	5,721	6,636
Noncash investing and financing activities:
Issuance of treasury stock for vested restricted stock awards and SARs	$ 4,913	$ 2,294	$ 1,256